Plus Therapeutics (PSTV) Equity Income (2011 - 2013)
Plus Therapeutics (PSTV) reported Equity Income of -$48000.0 for Q1 2013, up 4.0% year-over-year from -$46153.8 in Q1 2012, and down 29.73% quarter-over-quarter from -$37000.0 in Q4 2012.
Plus Therapeutics (PSTV) Equity Income (2011 - 2013) Analysis & Trends
Plus Therapeutics (PSTV) has 3 years of Equity Income data on file, last reported at -$48000.0 in Q1 2013.
- Equity Income for Q1 2013 came in at -$48000.0, up 4.0% year-over-year; the trailing twelve-month figure through Dec 2013 was -$48000.0 (up 71.08% YoY), and the FY2013 annual result was -$48000.0, up 70.91% from the prior year.
- Equity Income eased to -$48000.0 in Q1 2013 per PSTV's latest filing, from -$37000.0 in the prior quarter.
- Over five years, Equity Income peaked at -$37000.0 in Q2 2012 and troughed at -$56000.0 in Q2 2011.
- A 3-year average of -$47000.0 and a median of -$48000.0 in 2013 frame the typical range for Equity Income.
- On a YoY basis, Equity Income climbed as much as 33.93% in 2012 and fell as far as 8.7% in 2012.
- A 3-year view of Equity Income shows it stood at -$56000.0 in 2011, then surged by 33.93% to -$37000.0 in 2012, then dropped by 29.73% to -$48000.0 in 2013.
- Business Quant data shows PSTV's Equity Income at -$48000.0 in Q1 2013, -$37000.0 in Q4 2012, and -$42000.0 in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | -48,000.00 |
| Dec 31, 2012 | -37,000.00 |
| Sep 30, 2012 | -42,000.00 |
| Jun 30, 2012 | -37,000.00 |
| Mar 31, 2012 | -50,000.00 |
| Dec 31, 2011 | -56,000.00 |
| Sep 30, 2011 | -51,000.00 |
| Jun 30, 2011 | -56,000.00 |
| Mar 31, 2011 | -46,000.00 |